CACUL1 and cancer: MLN4924, which inactivates cullin E3 ligases by blocking the conjugation of the ubiquitin-like molecule Nedd8 to the cullin scaffold protein27, 28, has recently emerged as a novel anti-cancer agent 60, 61, 62.